QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Stopped early · Phase 1/Phase 2
Conditions studied: Advanced Squamous Non-Small Cell Lung Cancer
In brief
This is a global, multicenter, 2-part, open-label phase 1b and single-arm phase 2 study designed to evaluate the safety and efficacy of AMG 479 in combination with paclitaxel and carboplatin for the first-line treatment of advanced squamous non-small cell lung carcinoma.
Key facts
- Study ID
- NCT00807612
- Run by
- NantCell, Inc.
- People needed
- 15
- Starts
- 2009-01-01
- Expected to finish
- 2010-08-01
- Last updated by the study team
- 2024-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically or cytologically confirmed advanced squamous NSCLC
- Measurable disease as defined per modified RECIST criteria
- ECOG performance status of 0 or 1
- ≥18 years old
- Adequate glycemic function, for subjects with known diabetes
You may not qualify if…
- Untreated or symptomatic central nervous system (CNS) metastases
- Prior anti-cancer therapy as follows: Any prior chemotherapy for squamous NSCLC; Any prior adjuvant or neoadjuvant chemotherapy for squamous NSCLC; Any prior chemoradiation for squamous NSCLC; Central (chest) radiation therapy ≤ 28 days prior to enrollment, radiation therapy for peripheral lesions≤14 days prior to enrollment for squamous NSCLC
Where it is running
- Research Site — Fayetteville, Arkansas, United States
- Research Site — Fayetteville, Arkansas, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Lafayette, Indiana, United States
- Research Site — Lafayette, Indiana, United States
- Research Site — New Albany, Indiana, United States
- Research Site — New Albany, Indiana, United States
- Research Site — Paducah, Kentucky, United States
- Research Site — Paducah, Kentucky, United States
- Research Site — St Louis, Missouri, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Winston-Salem, North Carolina, United States
- Research Site — Winston-Salem, North Carolina, United States
- Research Site — Bethlehem, Pennsylvania, United States
- Research Site — Bethlehem, Pennsylvania, United States
- Research Site — Greenville, South Carolina, United States
- Research Site — Greenville, South Carolina, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — Madison, Wisconsin, United States
- Research Site — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.